155 related articles for article (PubMed ID: 37343365)
1. Evaluation of fentanyl immunoassay test strips for rapid in-situ detection of fentanyl and fentanyl analogs in seized samples and alternative matrices.
Norman C; Marland V; McKenzie C; Ménard H; Nic Daéid N
Int J Drug Policy; 2023 Aug; 118():104102. PubMed ID: 37343365
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a lateral flow immunoassay for the detection of the synthetic opioid fentanyl.
Angelini DJ; Biggs TD; Maughan MN; Feasel MG; Sisco E; Sekowski JW
Forensic Sci Int; 2019 Jul; 300():75-81. PubMed ID: 31078080
[TBL] [Abstract][Full Text] [Related]
3. Validation of a lateral flow chromatographic immunoassay for the detection of fentanyl in drug samples.
Park JN; Sherman SG; Sigmund V; Breaud A; Martin K; Clarke WA
Drug Alcohol Depend; 2022 Nov; 240():109610. PubMed ID: 36115223
[TBL] [Abstract][Full Text] [Related]
4. Assessing the limit of detection of Fourier-transform infrared spectroscopy and immunoassay strips for fentanyl in a real-world setting.
McCrae K; Tobias S; Grant C; Lysyshyn M; Laing R; Wood E; Ti L
Drug Alcohol Rev; 2020 Jan; 39(1):98-102. PubMed ID: 31746056
[TBL] [Abstract][Full Text] [Related]
5. Assessment of two brands of fentanyl test strips with 251 synthetic opioids reveals "blind spots" in detection capabilities.
Hayes KL; Lieberman M
Harm Reduct J; 2023 Dec; 20(1):175. PubMed ID: 38057832
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the sensitivity, stability, and cross-reactivity of commercial fentanyl immunoassay test strips.
Rodriguez-Cruz SE
J Forensic Sci; 2023 Sep; 68(5):1555-1569. PubMed ID: 37420315
[TBL] [Abstract][Full Text] [Related]
7. Testing the test strips: laboratory performance of fentanyl test strips.
Halifax JC; Lim L; Ciccarone D; Lynch KL
Harm Reduct J; 2024 Jan; 21(1):14. PubMed ID: 38238757
[TBL] [Abstract][Full Text] [Related]
8. Rapid and Sensitive Detection of Fentanyl and Its Analogs by a Novel Chemiluminescence Immunoassay.
Zhao JY; Uddin M; Unsihuay D; Butler W; Xia TW; Xu JZ; Wang S; Sheng X; Jannetto PJ; Wang P; Xia X
Clin Chem; 2024 Jul; 70(7):978-986. PubMed ID: 38757262
[TBL] [Abstract][Full Text] [Related]
9. Advances in fentanyl testing.
Uljon S
Adv Clin Chem; 2023; 116():1-30. PubMed ID: 37852717
[TBL] [Abstract][Full Text] [Related]
10. An urgent need for community lot testing of lateral flow fentanyl test strips marketed for harm reduction in Northern America.
Lieberman M; Badea A; Desnoyers C; Hayes K; Park JN
Harm Reduct J; 2024 Jun; 21(1):115. PubMed ID: 38877522
[TBL] [Abstract][Full Text] [Related]
11. High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips.
Lockwood TE; Vervoordt A; Lieberman M
Harm Reduct J; 2021 Mar; 18(1):30. PubMed ID: 33750405
[TBL] [Abstract][Full Text] [Related]
12. Detection of 30 Fentanyl Analogs by Commercial Immunoassay Kits.
Wharton RE; Casbohm J; Hoffmaster R; Brewer BN; Finn MG; Johnson RC
J Anal Toxicol; 2021 Feb; 45(2):111-116. PubMed ID: 33580693
[TBL] [Abstract][Full Text] [Related]
13. The use of lateral flow immunoassays for the detection of fentanyl in seized drug samples and postmortem urine.
Angelini DJ; Biggs TD; Prugh AM; Smith JA; Hanburger JA; Llano B; Avelar R; Ellis A; Lusk B; Malik Naanaa A; Sisco E; Sekowski JW
J Forensic Sci; 2021 Mar; 66(2):758-765. PubMed ID: 33275295
[TBL] [Abstract][Full Text] [Related]
14. Development of an UPLC-MS/MS method for the analysis of 16 synthetic opioids in segmented hair, and evaluation of the polydrug history in fentanyl analogue users.
Ramírez Fernández MDM; Wille SMR; Jankowski D; Hill V; Samyn N
Forensic Sci Int; 2020 Feb; 307():110137. PubMed ID: 31927248
[TBL] [Abstract][Full Text] [Related]
15. An LC-MS-MS Method for the Analysis of Carfentanil, 3-Methylfentanyl, 2-Furanyl Fentanyl, Acetyl Fentanyl, Fentanyl and Norfentanyl in Postmortem and Impaired-Driving Cases.
Sofalvi S; Schueler HE; Lavins ES; Kaspar CK; Brooker IT; Mazzola CD; Dolinak D; Gilson TP; Perch S
J Anal Toxicol; 2017 Jul; 41(6):473-483. PubMed ID: 28830122
[TBL] [Abstract][Full Text] [Related]
16. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples.
Green TC; Park JN; Gilbert M; McKenzie M; Struth E; Lucas R; Clarke W; Sherman SG
Int J Drug Policy; 2020 Mar; 77():102661. PubMed ID: 31951925
[TBL] [Abstract][Full Text] [Related]
17. Data-independent screening method for 14 fentanyl analogs in whole blood and oral fluid using LC-QTOF-MS.
Palmquist KB; Swortwood MJ
Forensic Sci Int; 2019 Apr; 297():189-197. PubMed ID: 30802648
[TBL] [Abstract][Full Text] [Related]
18. Review of analytical methods for screening and quantification of fentanyl analogs and novel synthetic opioids in biological specimens.
Palmquist KB; Truver MT; Shoff EN; Krotulski AJ; Swortwood MJ
J Forensic Sci; 2023 Sep; 68(5):1643-1661. PubMed ID: 37221651
[TBL] [Abstract][Full Text] [Related]
19. Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada.
Klaire S; Janssen RM; Olson K; Bridgeman J; Korol EE; Chu T; Ghafari C; Sabeti S; Buxton JA; Lysyshyn M
Int J Drug Policy; 2022 Aug; 106():103741. PubMed ID: 35671687
[TBL] [Abstract][Full Text] [Related]
20. Detecting fentanyl using point-of-care drug checking technologies: A validation study.
Ti L; Tobias S; Lysyshyn M; Laing R; Nosova E; Choi J; Arredondo J; McCrae K; Tupper K; Wood E
Drug Alcohol Depend; 2020 Jul; 212():108006. PubMed ID: 32438280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
